Skip to main content

Pellix

NDC 87143-300 · Perfero Pharma, Inc.

Generic namecalcipotriene
Dosage formSOLUTION
RouteTOPICAL
Active ingredient(s)CALCIPOTRIENE
Strength.05 mg/mL
Pharmacologic classVitamin D Analog [EPC], Vitamin D [CS]
Marketing categoryANDA

Packages

87143-300-60 — 1 BOTTLE, PLASTIC in 1 CARTON (87143-300-60) / 60 mL in 1 BOTTLE, PLASTIC

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0713-0318 — Calcipotriene, 0713-0848 — calcipotriene and betamethasone dipropionate, 16714-763 — calcipotriene, 45802-816 — Calcipotriene, Betamethasone Dipropionate, 51672-1402 — Calcipotriene and Betamethasone Dipropionate, 51672-4154 — Calcipotriene, 51672-5278 — Calcipotriene, 51862-376 — calcipotriene, 51862-512 — calcipotriene, 63629-2520 — Calcipotriene, Betamethasone Dipropionate, 63629-8617 — Calcipotriene, Betamethasone Dipropionate, 66993-877 — Calcipotriene, 66993-878 — calcipotriene, 68462-310 — Calcipotriene, 68462-501 — calcipotriene, 72162-1428 — Calcipotriene, Betamethasone Dipropionate, 73499-001 — Calcipotriene and Betamethasone dipropionate, 87143-100 — calcipotriene and betamethasone dipropionate

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels